Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial [PDF]
Kidney Research and Clinical Practice, 2018 Background : For phosphate control, patient education is essential due to the limited clearance of phosphate by dialysis. However, well-designed randomized controlled trials about dietary and phosphate binder education have been scarce.
Eunsoo Lim +11 more
doaj +5 more sources
Evaluation of cerium oxide as a phosphate binder using 5/6 nephrectomy model rat [PDF]
BMC Nephrology, 2022 Background The number of chronic kidney disease (CKD) patients continues to increase worldwide. CKD patients need to take phosphate binders to manage serum phosphorus concentrations.
Akiko Hashimoto +6 more
doaj +2 more sources
The role of kidney transplantation and phosphate binder use in vitamin K status. [PDF]
PLoS ONE, 2018 BACKGROUND:Cardiovascular disease is the leading cause of death in end-stage renal disease and is strongly associated with vascular calcification. Both kidney transplantation and phosphate binders may lower the risk of vascular calcification.
Thijs T Jansz +6 more
doaj +2 more sources
Interventional study to improve adherence to phosphate binder treatment in dialysis patients [PDF]
BMC Nephrology, 2019 Background Adherence to phosphate binder treatment is important to prevent high serum phosphate level in chronic dialysis patients. We therefore wanted to investigate patient knowledge, beliefs about and adherence to phosphate binders among these ...
Bodil Jahren Hjemås +4 more
doaj +2 more sources
Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide [PDF]
International Journal of Nephrology and Renovascular Disease, 2019 Kathryn Gray,1 Linda H Ficociello,2 Abigail E Hunt,1 Claudy Mullon,2 Steven M Brunelli1 1DaVita Clinical Research, Minneapolis, MN, USA; 2Medical Department, Fresenius Medical Care Renal Therapies Group, Waltham, MA, USA Background: Phosphate binders are
Gray K +4 more
doaj +2 more sources
Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study [PDF]
BMC Nephrology, 2019 Background Elevated serum phosphorus concentrations are common among maintenance hemodialysis patients. Protein is a major source of dietary phosphate, but restriction of protein intake can result in hypoalbuminemia and protein-energy wasting.
Kamyar Kalantar-Zadeh +6 more
doaj +2 more sources
Provider Attitudes and Support of Patients’ Autonomy for Phosphate Binder Medication Adherence in ESRD [PDF]
Journal of Patient Experience, 2020 This cross-sectional study of 56 dialysis providers from 3 dialysis clinics examined providers’ attitudes and perception of autonomy support for patients’ medication adherence behaviors. Respondents completed surveys assessing attitudes and perception of
Ebele M Umeukeje MD, MPH +4 more
doaj +2 more sources
Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients [PDF]
International Journal of Nephrology and Renovascular Disease, 2014 Kimberly F Farrand,1 J Brian Copley,1 Jamie Heise,1 Moshe Fridman,2 Michael S Keith,1 Lynne Poole3 1Shire, Wayne, PA, USA; 2AMF Consulting, Los Angeles, CA, USA; 3Shire, Basingstoke, UK Abstract: The purpose of this study was to conduct a retrospective ...
Farr +6 more
doaj +2 more sources
Lanthanum phosphate binder-induced iron deficiency anaemia. [PDF]
BMJ Case Rep, 2019 Lanthanum carbonate is a phosphate binder that is used to reduce serum phosphate levels in patients with end-stage renal disease (ESRD). Lanthanum forms insoluble lanthanum phosphate complexes that are supposed to pass through the gastrointestinal (GI) tract unabsorbed.
Awad C, Gilkison K, Shaw E.
europepmc +4 more sources
Pharmacology of the phosphate binder, lanthanum carbonate. [PDF]
Ren Fail, 2011 Studies were conducted to compare the phosphate-binding efficacy of lanthanum carbonate directly with other clinically used phosphate binders and to evaluate any potential adverse pharmacology. To examine the phosphate-binding efficacy, rats with normal renal function and chronic renal failure received lanthanum carbonate, aluminum hydroxide, calcium ...
Damment SJ.
europepmc +4 more sources